PPT-Clostridium difficile
Author : myesha-ticknor | Published Date : 2015-09-22
CDI Infections Toolkit Activity C ELC Prevention Collaboratives Draft 122309 Disclaimer The findings and conclusions in this presentation are those of the authors
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Clostridium difficile" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Clostridium difficile: Transcript
CDI Infections Toolkit Activity C ELC Prevention Collaboratives Draft 122309 Disclaimer The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Clostridium difficile . Infection (CDI). for Healthcare Providers. HAI Prevention Strategies Subcommittee. August 2011. These presentation slide sets were developed by the Prevention Strategies Subcommittee of the Arizona Healthcare-Associated Infection (HAI) Advisory Committee. Their works was guided by the best available evidence at the time this document was created. The objectives of the PSS are directed at providing access to additional resources for healthcare facilities, creating a repository of informational anc constructing a toolkit of strategies to assist facilities in preventing healthcare-associated infections.. Last reviewed 03/04/2016. . Disclaimer. : The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. Infection. Serin. a Tart, PharmD. Antimicrobial Stewardshi. p Coordinator Clinical Pharmacist. Cape Fear Valley Health. start@capefearvalley.com. . I have no relevant financial relationships with the manufacturers of any of the products discussed in this CE activity. Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH Associate Professor of Medicine Washington University School of Medicine infection (CDI) has become the most common cause of health-care associated infections in the United States.. The Centers for Disease Control and Prevention (CDC) classified . C. difficile. as an immediate public health threat that requires urgent and aggressive action . Welcome!. All lines are muted, so please ask your questions in chat. For technical issues, chat to the ‘Technical Support’ Panelist . Please actively participate in the poll that will pop up on the lower righthand side of your screen at the end of the presentation. A number of distinct ‘O’ serotypes of . E. coli . possess both the genes necessary for adherence and plasmids encoding two distinct enterotoxins (. verotoxins. ), which are identical to the toxins produced by . Prior studies show that 3 - 26% of hospitalized patients are asymptomatically colonized with C. difficile . Available assays are not able to distinguish between C. difficile infection and coloniz Owners Clostridium difficile is an important cause of disease in people and animals. These bacteria do two very important things: Some strains contain genes that allow them to produce toxins. It i Chapter 13: Updated: Potential Food Safety Hazard Control Measures FDA Guideline Growth Heat Resistance Analytical Procedures o Food sampling and preparation of sample homoge Levy P, Fournier P, Lotte L, Million M, Brouqui P, Raoult D. Clostridium tetani Osteitis without Tetanus. Emerg Infect Dis. 2014;20(9):1571-1573. https://doi.org/10.3201/eid2009.131579. Clostridioides. Difficile. Infection. Levi Teigen, PhD, RD. May 11, 2021. Objectives. Recognize the nutritional implications of a . C. difficile . infection at both a systemic and local (i.e. colonic) level.
Download Document
Here is the link to download the presentation.
"Clostridium difficile"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents